Biotech

All Articles

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will definitely list on the NYSE American inventory substitution this mo...

ALX's waning CD47 feedback fee sends out stock spiraling down

.ALX Oncology's stage 2 gastric cancer reaction cost has actually weakened. After seeing its own CD4...

Ionis axes eye disease from intendeds of Roche-partnered possibility after data disappoint

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of desire...

Biogen's chief executive officer pointed out no risky sell 2023. He's ready to become daring

.While Biogen's pharma peers are actually seeking for late-stage properties with little bit of risk,...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has been a biotech in search of a pipe after it ditched its own lead assets over the fin...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back rights to a very early Alzheimer's condition system to Denali Rehab...

Takeda taps brand-new mind of US oncology company-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and als...

Vertex, beaten by AATD once again, loses 2 properties on discard heap

.Vertex's effort to alleviate an unusual hereditary condition has reached one more problem. The biot...

Vir increases 3 T-cell engagers coming from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter earnings report had not been short of big news. The provider inv...

Galapagos stops briefly CAR-T tissue therapy litigation over Parkinsonism situation

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T cell therapy, pushin...